Free shipping on all orders over $ 500

Darusentan

Cat. No. M28831

All AbMole products are for research use only, cannot be used for human consumption.

Darusentan Structure
Synonym:

Lu-135252

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Darusentan (Lu-135252) is a selective endothelin receptor A (ET-A) receptor antagonist, which binds with a Ki of 1.4 nM to the ET-A receptor and a Ki of 184 nM to ET-B receptor, respectively with a 100-fold selectivity for ETA rather than ETB receptors. Darusentan competes for radiolabeled endothelin binding in rat aortic vascular smooth muscle cells (RAVSMs) membranes with single-site kinetics, exhibiting a Ki of 13 nM.

Chemical Information
Molecular Weight 410.42
Formula C22H22N2O6
CAS Number 171714-84-4
Form Solid
Solubility (25°C) DMSO 100 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Faquan Liang, et al. Can J Physiol Pharmacol. Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteries

[2] Frank Enseleit, et al. Ther Adv Cardiovasc Dis. Darusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension

[3] Frank Enseleit, et al. Curr Hypertens Rep. Darusentan in resistant hypertension: lost in translation

[4] Frank Enseleit, et al. Expert Opin Investig Drugs. Darusentan: a new perspective for treatment of resistant hypertension?

[5] Roumen Nakov, et al. Am J Hypertens. Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension

Related Endothelin Receptor Products
Zibotentan

Zibotentan (ZD4054) is a more selective and specific endothelin-A receptor (ETAR) antagonist with an IC50 value of 21 nM.

Ambrisentan

Ambrisentan is an orally active, highly selective antagonist of the endothelin-1 type A receptor.

Sitaxsentan sodium

Sitaxsentan (TBC-11251) is an orally active, highly selective antagonist of endothelin A receptors.

Macitentan

Macitentan is an orally-active, tissue-targeting dual ET receptor antagonist.

Bosentan Hydrate

Bosentan is an endothelin (ET) receptors antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Darusentan, Lu-135252 supplier, Endothelin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.